Massimo Gangitano
Overview
Explore the profile of Massimo Gangitano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lattanzi S, Dono F, dOrsi G, DAniello A, Panebianco M, Bonanni P, et al.
Epilepsia
. 2025 Mar;
PMID: 40088187
Objective: Cenobamate is an antiseizure medication (ASM) with a dual mechanism of action that was recently approved for the treatment of focal seizures in adults. This analysis aimed to describe...
2.
Lattanzi S, Canafoglia L, Canevini M, Casciato S, Cerulli Irelli E, Chiesa V, et al.
Neurol Ther
. 2025 Mar;
PMID: 40069539
Introduction: Subjects with intellectual disability are usually excluded from clinical trials and there is limited evidence-based guidance for the choice of antiseizure medications in this vulnerable population. The study explored...
3.
Lattanzi S, Canafoglia L, Canevini M, Casciato S, Cerulli Irelli E, Chiesa V, et al.
Epilepsia
. 2023 Dec;
64(11):2922-2933.
PMID: 38079181
Objective: This study aimed to explore the effectiveness of brivaracetam (BRV) according to baseline seizure frequency and past treatment history in subjects with focal epilepsy who were included in the...
4.
Alonge P, Di Stefano V, Lupica A, Gangitano M, Torrente A, Pignolo A, et al.
Brain Sci
. 2023 Jan;
13(1).
PMID: 36671992
Background: chronic idiopathic demyelinating polyneuropathy (CIDP) is an acquired, immune-mediated neuropathy characterized by weakness, sensory symptoms and significant reduction or loss of deep tendon reflexes evolving over 2 months at...
5.
Di Stefano V, Iacono S, Gagliardo A, Maggio B, Guggino G, Gangitano M, et al.
Pain Res Manag
. 2022 Oct;
2022:7355102.
PMID: 36199588
Objectives: Fibromyalgia (FM) is characterized by spontaneous chronic widespread pain in combination with hyperalgesia to pressure stimuli. Sound-induced flash illusions (SIFIs) reflect cross-modal interactions between senses allowing to assess a...
6.
Lattanzi S, Canafoglia L, Canevini M, Casciato S, Cerulli Irelli E, Chiesa V, et al.
Neurol Ther
. 2022 Sep;
11(4):1789-1804.
PMID: 36109431
Introduction: In randomized controlled trials, add-on brivaracetam (BRV) reduced seizure frequency in patients with drug-resistant focal epilepsy. Most real-world research on BRV has focused on refractory epilepsy. The aim of...
7.
Lattanzi S, Canafoglia L, Canevini M, Casciato S, Cerulli Irelli E, Chiesa V, et al.
Drugs Aging
. 2022 Mar;
39(4):297-304.
PMID: 35344198
Background: The management of epilepsy in older adults has become part of daily practice because of an aging population. Older patients with epilepsy represent a distinct and more vulnerable clinical...
8.
Lattanzi S, Canafoglia L, Canevini M, Casciato S, Cerulli Irelli E, Chiesa V, et al.
Seizure
. 2022 Mar;
97:37-42.
PMID: 35320736
Objective: Post-stroke epilepsy (PSE) is one of the most common causes of acquired epilepsy and accounts for about 10-15% of all newly diagnosed epilepsy cases. However, evidence about the clinical...
9.
Lattanzi S, Ascoli M, Canafoglia L, Canevini M, Casciato S, Cerulli Irelli E, et al.
Epilepsia
. 2022 Mar;
63(5):e42-e50.
PMID: 35278335
The maintenance of seizure control over time is a clinical priority in patients with epilepsy. The aim of this study was to assess the sustained seizure frequency reduction with adjunctive...
10.
Lattanzi S, Canafoglia L, Canevini M, Casciato S, Chiesa V, Dainese F, et al.
CNS Drugs
. 2021 Nov;
35(12):1329-1331.
PMID: 34787838
No abstract available.